ARTICLE | Distillery Techniques

Drug platforms

July 31, 2017 7:18 PM UTC

Structural analyses of BAX bound to a positive allosteric modulator (PAM) could guide the design of BAX-targeting PAMs for cancer. NMR-based screening and in vitro binding and activity assays of a lib...

BCIQ Company Profiles

Harvard Medical School

BCIQ Target Profiles

BCL2-associated X protein